Holdings
Squadron Capital Management LLC
As of Sep 30, 2026, Squadron Capital Management LLC reported 31 positions worth US$314M. Largest: Kodiak Sciences Inc, C4 Therapeutics, Inc. and Cogent Biosciences, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Kodiak Sciences Inc | 420K | US$39.8M | −80,000 | Sep 30, 2026 |
| C4 Therapeutics, Inc. | 9.32M | US$31M | +2.12M | Sep 30, 2026 |
| Cogent Biosciences, Inc. | 915K | US$29.3M | +50,000 | Sep 30, 2026 |
| Silence Therapeutics PLC | 2.08M | US$22.8M | new | Sep 30, 2026 |
| Zentalis Pharmaceuticals, Inc. | 6.83M | US$18.9M | +3.13M | Sep 30, 2026 |
| Edgewise Therapeutics, Inc. | 425K | US$17.3M | +135K | Sep 30, 2026 |
| Relay Therapeutics, Inc. | 785K | US$14.2M | −185K | Sep 30, 2026 |
| ORIC Pharmaceuticals, Inc. | 1M | US$13.5M | new | Sep 30, 2026 |
| Relmada Therapeutics, Inc. | 3.5M | US$13.2M | −3.85M | Sep 30, 2026 |
| Definium Therapeutics, Inc. | 340K | US$12.9M | +255K | Sep 30, 2026 |